Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 Nucleocapsid
Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgM vs N
Testing Method Category
Testing Method
in house
Testing Method - Additional Info
homogeneous cell-based HTS system using AlphaLISA detection technology
Reported Performance
Remark: high sensitivity and large dynamic range
Sample Size
/
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements